Featured/ SION/ 08/10/2026 · 8:08 AM Sionna Therapeutics Stock Plunges After Cystic Fibrosis Trial Failure; Vertex Rises on Reduced Competition Will not advance SION-719 add-on; Vertex sees relief from rivalry.